 | • レポートコード：MRC2-11QY11472 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は結膜炎治療薬のグローバル市場について調査・分析したレポートです。種類別（抗生物質、肥満細胞安定剤、ステロイド、その他）市場規模、用途別（病院、自己管理）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別結膜炎治療薬の競争状況、市場シェア ・世界の結膜炎治療薬市場：種類別市場規模 2015年-2020年（抗生物質、肥満細胞安定剤、ステロイド、その他） ・世界の結膜炎治療薬市場：種類別市場規模予測 2021年-2026年（抗生物質、肥満細胞安定剤、ステロイド、その他） ・世界の結膜炎治療薬市場：用途別市場規模 2015年-2020年（病院、自己管理） ・世界の結膜炎治療薬市場：用途別市場規模予測 2021年-2026年（病院、自己管理） ・北米の結膜炎治療薬市場分析：米国、カナダ ・ヨーロッパの結膜炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの結膜炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の結膜炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの結膜炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Akorn Pharmaceuticals、Alcon/ Novartis、Allergan、Bausch & Lomb、Bausch Health、Merck、Actavis、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Conjunctivitis, or pink eye, is inflammation of the outermost layer of the white part of the eye and the inner surface of the eyelid due to numerous causes the most common being bacterial infection. The condition is self-limiting, but in some cases results in kerato-conjunctivitis, which results in blurred vision. The viral and bacterial conjunctivitis results in highly infectious watery discharge which is extremely contagious.
The market for conjunctivitis is growing at a moderate rate. The growth factors for the growth of global conjunctivitis drugs market are rise in hygiene and awareness, growing expenditure on health, greater exposure to allergens and infective agents, the contagious nature of the disease etc. However the market is restrained by many factors such as the self-limiting nature of the disease, off label drug use,
Market Analysis and Insights: Global Conjunctivitis Drugs Market
The global Conjunctivitis Drugs market size is projected to reach US$ 885.9 million by 2026, from US$ 869.4 million in 2020, at a CAGR of 1.8%% during 2021-2026.
Global Conjunctivitis Drugs Scope and Market Size
Conjunctivitis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Conjunctivitis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Akorn Pharmaceuticals
Alcon/ Novartis
Allergan
Bausch & Lomb
Bausch Health
Merck
Actavis
Pfizer
Market segment by Type, the product can be split into
Antibiotics
Mast Cell Stabilizers
Steroids
Others
Market segment by Application, split into
Hospitals
Self-Administered
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Conjunctivitis Drugs Revenue
1.4 Market by Type
1.4.1 Global Conjunctivitis Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 Mast Cell Stabilizers
1.4.4 Steroids
1.4.5 Others
1.5 Market by Application
1.5.1 Global Conjunctivitis Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Self-Administered
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Conjunctivitis Drugs Market Perspective (2015-2026)
2.2 Global Conjunctivitis Drugs Growth Trends by Regions
2.2.1 Conjunctivitis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Conjunctivitis Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Conjunctivitis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Conjunctivitis Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Conjunctivitis Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Conjunctivitis Drugs Players by Market Size
3.1.1 Global Top Conjunctivitis Drugs Players by Revenue (2015-2020)
3.1.2 Global Conjunctivitis Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Conjunctivitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Conjunctivitis Drugs Market Concentration Ratio
3.2.1 Global Conjunctivitis Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Conjunctivitis Drugs Revenue in 2019
3.3 Conjunctivitis Drugs Key Players Head office and Area Served
3.4 Key Players Conjunctivitis Drugs Product Solution and Service
3.5 Date of Enter into Conjunctivitis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Conjunctivitis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Conjunctivitis Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Conjunctivitis Drugs Market Size by Application (2015-2020)
5.2 Global Conjunctivitis Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Conjunctivitis Drugs Market Size (2015-2020)
6.2 Conjunctivitis Drugs Key Players in North America (2019-2020)
6.3 North America Conjunctivitis Drugs Market Size by Type (2015-2020)
6.4 North America Conjunctivitis Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Conjunctivitis Drugs Market Size (2015-2020)
7.2 Conjunctivitis Drugs Key Players in Europe (2019-2020)
7.3 Europe Conjunctivitis Drugs Market Size by Type (2015-2020)
7.4 Europe Conjunctivitis Drugs Market Size by Application (2015-2020)
8 China
8.1 China Conjunctivitis Drugs Market Size (2015-2020)
8.2 Conjunctivitis Drugs Key Players in China (2019-2020)
8.3 China Conjunctivitis Drugs Market Size by Type (2015-2020)
8.4 China Conjunctivitis Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Conjunctivitis Drugs Market Size (2015-2020)
9.2 Conjunctivitis Drugs Key Players in Japan (2019-2020)
9.3 Japan Conjunctivitis Drugs Market Size by Type (2015-2020)
9.4 Japan Conjunctivitis Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Conjunctivitis Drugs Market Size (2015-2020)
10.2 Conjunctivitis Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Conjunctivitis Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Conjunctivitis Drugs Market Size by Application (2015-2020)
11 India
11.1 India Conjunctivitis Drugs Market Size (2015-2020)
11.2 Conjunctivitis Drugs Key Players in India (2019-2020)
11.3 India Conjunctivitis Drugs Market Size by Type (2015-2020)
11.4 India Conjunctivitis Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Conjunctivitis Drugs Market Size (2015-2020)
12.2 Conjunctivitis Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Conjunctivitis Drugs Market Size by Type (2015-2020)
12.4 Central & South America Conjunctivitis Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Akorn Pharmaceuticals
13.1.1 Akorn Pharmaceuticals Company Details
13.1.2 Akorn Pharmaceuticals Business Overview
13.1.3 Akorn Pharmaceuticals Conjunctivitis Drugs Introduction
13.1.4 Akorn Pharmaceuticals Revenue in Conjunctivitis Drugs Business (2015-2020))
13.1.5 Akorn Pharmaceuticals Recent Development
13.2 Alcon/ Novartis
13.2.1 Alcon/ Novartis Company Details
13.2.2 Alcon/ Novartis Business Overview
13.2.3 Alcon/ Novartis Conjunctivitis Drugs Introduction
13.2.4 Alcon/ Novartis Revenue in Conjunctivitis Drugs Business (2015-2020)
13.2.5 Alcon/ Novartis Recent Development
13.3 Allergan
13.3.1 Allergan Company Details
13.3.2 Allergan Business Overview
13.3.3 Allergan Conjunctivitis Drugs Introduction
13.3.4 Allergan Revenue in Conjunctivitis Drugs Business (2015-2020)
13.3.5 Allergan Recent Development
13.4 Bausch & Lomb
13.4.1 Bausch & Lomb Company Details
13.4.2 Bausch & Lomb Business Overview
13.4.3 Bausch & Lomb Conjunctivitis Drugs Introduction
13.4.4 Bausch & Lomb Revenue in Conjunctivitis Drugs Business (2015-2020)
13.4.5 Bausch & Lomb Recent Development
13.5 Bausch Health
13.5.1 Bausch Health Company Details
13.5.2 Bausch Health Business Overview
13.5.3 Bausch Health Conjunctivitis Drugs Introduction
13.5.4 Bausch Health Revenue in Conjunctivitis Drugs Business (2015-2020)
13.5.5 Bausch Health Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Conjunctivitis Drugs Introduction
13.6.4 Merck Revenue in Conjunctivitis Drugs Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Actavis
13.7.1 Actavis Company Details
13.7.2 Actavis Business Overview
13.7.3 Actavis Conjunctivitis Drugs Introduction
13.7.4 Actavis Revenue in Conjunctivitis Drugs Business (2015-2020)
13.7.5 Actavis Recent Development
13.8 Pfizer
13.8.1 Pfizer Company Details
13.8.2 Pfizer Business Overview
13.8.3 Pfizer Conjunctivitis Drugs Introduction
13.8.4 Pfizer Revenue in Conjunctivitis Drugs Business (2015-2020)
13.8.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Conjunctivitis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Conjunctivitis Drugs Revenue
Table 3. Ranking of Global Top Conjunctivitis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Conjunctivitis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotics
Table 6. Key Players of Mast Cell Stabilizers
Table 7. Key Players of Steroids
Table 8. Key Players of Others
Table 9. Global Conjunctivitis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Conjunctivitis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Conjunctivitis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Conjunctivitis Drugs Market Share by Regions (2015-2020)
Table 13. Global Conjunctivitis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Conjunctivitis Drugs Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Conjunctivitis Drugs Market Growth Strategy
Table 19. Main Points Interviewed from Key Conjunctivitis Drugs Players
Table 20. Global Conjunctivitis Drugs Revenue by Players (2015-2020) (Million US$)
Table 21. Global Conjunctivitis Drugs Market Share by Players (2015-2020)
Table 22. Global Top Conjunctivitis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Conjunctivitis Drugs as of 2019)
Table 23. Global Conjunctivitis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Conjunctivitis Drugs Product Solution and Service
Table 26. Date of Enter into Conjunctivitis Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 29. Global Conjunctivitis Drugs Market Size Share by Type (2015-2020)
Table 30. Global Conjunctivitis Drugs Revenue Market Share by Type (2021-2026)
Table 31. Global Conjunctivitis Drugs Market Size Share by Application (2015-2020)
Table 32. Global Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 33. Global Conjunctivitis Drugs Market Size Share by Application (2021-2026)
Table 34. North America Key Players Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Conjunctivitis Drugs Market Share (2019-2020)
Table 36. North America Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. North America Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 38. North America Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. North America Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 40. Europe Key Players Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Conjunctivitis Drugs Market Share (2019-2020)
Table 42. Europe Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 44. Europe Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 46. China Key Players Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 47. China Key Players Conjunctivitis Drugs Market Share (2019-2020)
Table 48. China Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. China Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 50. China Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. China Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 52. Japan Key Players Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Conjunctivitis Drugs Market Share (2019-2020)
Table 54. Japan Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 56. Japan Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Conjunctivitis Drugs Market Share (2019-2020)
Table 60. Southeast Asia Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 62. Southeast Asia Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 64. India Key Players Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 65. India Key Players Conjunctivitis Drugs Market Share (2019-2020)
Table 66. India Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. India Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 68. India Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. India Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Conjunctivitis Drugs Market Share (2019-2020)
Table 72. Central & South America Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 74. Central & South America Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 76. Akorn Pharmaceuticals Company Details
Table 77. Akorn Pharmaceuticals Business Overview
Table 78. Akorn Pharmaceuticals Product
Table 79. Akorn Pharmaceuticals Revenue in Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 80. Akorn Pharmaceuticals Recent Development
Table 81. Alcon/ Novartis Company Details
Table 82. Alcon/ Novartis Business Overview
Table 83. Alcon/ Novartis Product
Table 84. Alcon/ Novartis Revenue in Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 85. Alcon/ Novartis Recent Development
Table 86. Allergan Company Details
Table 87. Allergan Business Overview
Table 88. Allergan Product
Table 89. Allergan Revenue in Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 90. Allergan Recent Development
Table 91. Bausch & Lomb Company Details
Table 92. Bausch & Lomb Business Overview
Table 93. Bausch & Lomb Product
Table 94. Bausch & Lomb Revenue in Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 95. Bausch & Lomb Recent Development
Table 96. Bausch Health Company Details
Table 97. Bausch Health Business Overview
Table 98. Bausch Health Product
Table 99. Bausch Health Revenue in Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 100. Bausch Health Recent Development
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Product
Table 104. Merck Revenue in Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 105. Merck Recent Development
Table 106. Actavis Company Details
Table 107. Actavis Business Overview
Table 108. Actavis Product
Table 109. Actavis Revenue in Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 110. Actavis Recent Development
Table 111. Pfizer Business Overview
Table 112. Pfizer Product
Table 113. Pfizer Company Details
Table 114. Pfizer Revenue in Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 115. Pfizer Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Conjunctivitis Drugs Market Share by Type: 2020 VS 2026
Figure 2. Antibiotics Features
Figure 3. Mast Cell Stabilizers Features
Figure 4. Steroids Features
Figure 5. Others Features
Figure 6. Global Conjunctivitis Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Self-Administered Case Studies
Figure 9. Conjunctivitis Drugs Report Years Considered
Figure 10. Global Conjunctivitis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Conjunctivitis Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Conjunctivitis Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Conjunctivitis Drugs Market Share by Players in 2019
Figure 15. Global Top Conjunctivitis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Conjunctivitis Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Conjunctivitis Drugs Revenue in 2019
Figure 17. North America Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
ウイルス性結膜炎治療薬の世界市場（～2026年） Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely t…- 細菌性結膜炎薬の世界市場（～2026年） Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis …
- ウイルス性結膜炎パイプライン薬剤の世界市場（～2026年） Market Analysis and Insights: Global Viral Conjunctivitis Pipeline Drugs Market The global Viral Conjunctivitis Pipeline Drugs market size is projected to reach US$ 51 million by 2026, from US$ 36 million in 2020, at a CAGR of 39.5%% during 2021-2026. Global Viral Conjunctivitis Pipeline Drugs Scope…
- アレルギー性結膜炎の世界市場（～2026年） Allergic conjunctivitis is an eye inflammation caused by an allergic reaction to substances like pollen or mold spores. There are different types of allergic conjunctivitis such as seasonal allergic conjunctivitis, perennial allergic conjunctivitis, giant papillary conjunctivitis, vernal kerato conj…
- 細菌性結膜炎治療の世界市場（～2026年） Bacterial conjunctivitis is a serious eye infection caused by several types of bacteria. The aforementioned figures clarify that it is one of the most common eye problems affecting people of all ages across the U.S. Such higher prevalence of the disease definitely prompts at increasing demand for ef…